Literature DB >> 9589894

Distribution of VIP receptors in the human submandibular gland: an immunohistochemical study.

T Kusakabe1, H Matsuda, Y Gono, T Kawakami, K Kurihara, M Tsukuda, T Takenaka.   

Abstract

Distribution of vasoactive intestinal polypeptide (VIP)-immunoreactive nerve fibers and VIP-receptor (VIP-R)-immunoreactive sites in the human submandibular gland were examined by the peroxidase-antiperoxidase method using the specimens taken from patients that had not received radiotherapy. VIP-immunoreactive fibers were found around both serous and mucous acini, the duct system, and those around the mucous acini were more numerous than those around the serous acini. VIP-R immunoreactivity was restricted to the mucous acini and the intercalated duct segment. The serous acini, striated duct, and excretory ducts lacked VIP-R immunoreactivity. These findings suggest that the mucous acinar cells contain VIP-R, and that VIP-R-mediated VIP action is involved in regulating synthesis of viscous saliva and its release.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9589894     DOI: 10.14670/HH-13.373

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  3 in total

1.  VIP and muscarinic synergistic mucin secretion by salivary mucous cells is mediated by enhanced PKC activity via VIP-induced release of an intracellular Ca2+ pool.

Authors:  David J Culp; Z Zhang; R L Evans
Journal:  Pflugers Arch       Date:  2020-01-13       Impact factor: 3.657

2.  Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome.

Authors:  B M Lodde; F Mineshiba; J Wang; A P Cotrim; S Afione; P P Tak; B J Baum
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

3.  Characterization of Prejunctional Muscarinic Receptors: Effects on the Release of VIP and Functional Responses and Receptor Expression in the Ovine Submandibular Gland.

Authors:  Anders T Ryberg; Ondrej Soukup; Gunnar Tobin
Journal:  Adv Pharmacol Sci       Date:  2009-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.